Home » OSTEOTECH RECEIVES ITS FIRST GRAFTON DMB 510(K) FDA CLEARANCE
OSTEOTECH RECEIVES ITS FIRST GRAFTON DMB 510(K) FDA CLEARANCE
November 30, 2005
Osteotech, Inc. announced today that the Food and Drug Administration ("FDA")
has cleared its 510(k) for Grafton Plus DBM Paste for use as a bone graft extender,
bone graft substitute and bone void filler in orthopedic procedures.